Research Centre for Biomedical Engineering

SOCIETAT PANTALLA - SESSIÓ 2: Els nous divulgadors: informar o predicar?
2022-03-09 10:00 - 12:00 UTC
Qui i què es comunica avui dia? Com han canviat el big data i la intel·ligència artificial el periodisme i la comunicació? S’ha democratitzat la informació? El fet que tothom pugui ser divulgador i comunicador permet oferir més diversitat i qualitat en la informació? Quin és el negoci darrere de la generació d’aquests continguts que es pugen a les plataformes? Quina societat estem creant des del punt de vista informatiu?
Amb Xantal Llavina (directora i presentadora de Revolució 4.0 a Catalunya Ràdio i TV3), Gemma Galdón (sociòloga i fundadora d’Eticas Research & Consulting) i Roc Massaguer (periodista i youtuber pioner @Outconsumer).

Xartec Salut - TAULA RODONA - "Brain Drain in the spanish framework"
2022-03-10 12:00 - 14:00
Dins dels serveis d’innovació oferts per la Xartec Salut hi ha l’Observatori, que pretén ser un catalitzador per a l’intercanvi de coneixement entre la xarxa, l’ecosistema HealthTech i la societat. L’última publicació de l’Observatori (“Brain Drain on the Spanish Network“) té el propòsit d’analitzar les principals causes i l’impacte del fenomen de la fuga de talent i, amb això, convidar a la reflexió i al diàleg.

En aquest sentit i sobre aquest tema, Xartec Salut conjuntament amb el CREB, ha organitzat una taula rodona que té l’objectiu d’identificar línies de treball i propostes concretes des d’un punt de vista constructiu al voltant d’aquesta problemàtica.

10 de març a l’Aula Capella de la UPC – ETSEIB (Avinguda Diagonal, 647, 08028 Barcelona), a les 12h00.

SOCIETAT PANTALLA – SESSIÓ 3: La construcció social des de darrera la pantalla
2022-03-16 10:00 - 12:00
Són les finalitats de les plataformes i les xarxes socials tan idealistes com defensen els seus fundadors? Quin ús tenen o poden tenir les nostres dades? Tenen fronteres, les dades? Què desconeixem de les plataformes i les xarxes socials? Quins paràmetres se segueixen per a definir els algorismes? A qui afavoreixen?
Amb Esther Paniagua (periodista i autora especialitzada en ciència i tecnologia), Nuria Oliver (directora de recerca en ciències de dades a Vodafone i del DataPop Alliance) i Karina Gibert (catedràtica i directora d’Intelligent Data Science & AI de la UPC).

Xartec Salut - TRAINING PILL - How to obtain the CE Mark with Medical Devices: Introduction to the EU MDR 2017/745
2022-03-17 11:00 - 12:30
How to obtain the CE Mark with Medical Devices: Introduction to the EU MDR 2017/745
– Carmen Martín –
Brief description of the session / register
Medical technologies are the top technical field in patent applications in Europe since 2020. However, only a small percentage of these patents obtain the CE Mark, which is one of the most important milestones. European certification requires meticulous planning by the manufacturer from a regulatory perspective. In order to ensure that medical devices are safe, this training lays the foundation for regulatory planning, beginning with the classification of the device, the EU regulatory ecosystem, the conformity assessment procedure, the clinical evaluation, the development of the technical documentation, and the requirements for quality management system certification and registration.
Carmen Martín has a career of more than 25 years of experience in Regulatory Affairs, Clinical Research and Quality Assurance, working with the Medical Devices Industry. Carmen is an expert in ensuring that regulatory strategies are conducted effectively to meet business objectives and legal requirements as well as protect life and human health. Carmen has led over 200 internal and external audits as a lead auditor and technical product specialist for Medical Devices and In-Vitro Diagnostic devices as well as their manufacturers. Carmen is also a MedTech guest speaker in the start-up and university ecosystem.

Xartec Salut - TRAINING PILL - "Key points to successfully protect your inventions by patents, copyright and know-how"
2022-03-31 11:00 - 12:30
“Key points to successfully protect your inventions by patents, copyright and know-how”
– Bernabé Zea –
Description of the session /register
This talk, aimed especially at researchers, will explain the steps to be taken to obtain adequate protection for inventions in order to facilitate the transfer of technology and, ultimately, its commercialization and monetization.
First, the different forms of protection (patents, know-how and copyright) will be briefly described, as well as the requirements for obtaining them. The concept of freedom to operate associated with the product or service to be commercialized will also be explained.
The difference between invention and commercial product will then be clarified. How it is possible to protect different aspects of the product through different patents, or by using different forms of protection. How to extrapolate protection from concrete solutions found in the laboratory, to broad inventions that can offer protection to a much more commercially interesting platform will also be covered.
There are certain discoveries that are not patentable. In addition, in recent years the criteria for exceptions to patentability that exist in Europe and the USA have been separated and have become much more demanding in the USA, especially in the area of diagnostics. What can and cannot be protected in both territories will be explained.
Software, an indispensable element in many medical devices, will be given special consideration, as it is patent-protectable under certain conditions, but can also be protected by copyright. How to take advantage of this dual protection will be explained. Protection through know-how may sometimes be the best route to follow, this too will be explained.
In the case of patents, the different existing protection routes, the times associated with protection and also the costs will be discussed. So that the researcher can adjust the protection to the timescale of their research. It will also be explained which experiments are necessary to achieve better protection, so that the effectiveness of the experimental results can be maximized.
Finally, different examples will be used to facilitate the practical application of the course content covered. A compilation will be made of the key ideas that any researcher or innovation manager should know about the protection of inventions.

Bernabé Zea is founding partner of ZBM Patents & Trademarks, one of the most reputed Spanish patent firms. Bernabé has extensive experience in preparing patentability, infringement and freedom-to- operate opinions, negotiating patent licences, conducting due diligence and drafting patents. His practice focuses on organic chemistry and pharmacy, but also includes biotechnology and biochemistry.
He frequently acts as an expert in patent court actions before Spanish courts. He has acted as a technical expert both within and outside Spain in many cases involving blockbuster drugs such as atorvastatin, escitalopram, alendronate, tamsulosine, venlafaxine and the most recent cases of fulvestrant and pemetrexed.
Bernabé is CEO of ZBM BConnect a consultancy firm that assists private companies and public research institutions when optimizing their technology transfer activities. His main duties in ZBM BC are the management of the company, obtaining technology from companies and other institutions and conducting negotiations to transfer the technology.
He started teaching at the Patent Centre of the University of Barcelona in 1988. He is an expert in searching patent and scientific literature, as he was a representative of both STN International and Chemical Abstracts Service in Spain for over 10 years. Before this, he worked for Questel-Orbit. He currently combines his position as partner at ZBM with his position as professor at the University of Barcelona.
Since 1988 he has lectured regularly on patent matters on courses organised by the Spanish Patent and Trademark Office and the Patent Centre of the University of Barcelona, as well as on the main Spanish master’s programmes on intellectual property. He has authored several
articles on patent matters and patent documentation in Spanish newspapers and specialised journals.
Finally, Bernabé is vicepresident of Ahead Therapeutics. This start-up biotech company uses a proprietary technology to develop treatments for different autoimmune disorders.

Xartec Salut - TRAINING PILL - New changes introduced by EN ISO 14155:2020 in clinical investigations with medical devices
2022-04-07 11:00 - 12:30
New changes introduced by EN ISO 14155:2020 in clinical investigations with medical devices
– Maria Nyakern –
Brief description of the session /register
The ISO 14155:2020 (Clinical investigation of medical devices for human subjects – Good Clinical Practice) is the third edition of this standard of reference for the design, conduct, recording, and reporting of medical device clinical studies. It provides guidance to manufacturers and clinical research professionals on how to implement Good Clinical Practice (GCP) for pre and post-market clinical investigations designed to determine the safety and performance of a medical device. This session will focus on the new requirements introduced by the ISO 14155:2020, summarizing the differences with the prior version and putting in the context of the EU Medical Device Regulation (MDR 2017/745).
Maria Nyåkern is the President and CEO, leading the company to align the organization to its expansion in the medical device B2B sector. Dr Nyåkern founded AKRN Scientific Consulting in 2018 after working nearly 15 years in the regulatory and clinical development of medical devices technology at multiple medical device companies such as Cordis JnJ, Trivascular Inc, Medtronic and Abbott. Maria Nyåkern is a Doctor of Cell Biology at Stockholm University, Sweden (2003), and has completed a Postdoctoral Fellowship at the University of Bologna, Italy (2006). She is fluent in English, Spanish, Italian, French and Swedish.

Xartec Salut – TRAINING PILL – Software Inventions in the Medical Field
2022-04-21 11:00 - 12:30
Xartec Salut – TRAINING PILL – Software Inventions in the Medical Field
In Europe and many other jurisdictions, inventions relating to software can face specific additional hurdles to patentability. Furthermore, the growth in software automation and Artificial Intelligence means that advancements in the medical field increasingly fall within the domain of software inventions. Although software inventions “per se” are excluded from patentability, it is possible to achieve grant if certain requirements are met.

# GUSTAVO FUSTER BIO
He holds a Degree in Pharmacy from the Complutense University of Madrid and MBA (Biotechnology) (Aliter). He studied Law at the Spanish National University of Distance Education (UNED). He held the position of Business Development and Patents Manager at the biotechnology firm Genetrix Corp (gaining experience in the field of monoclonal antibodies and adult stem cell technology). He was Patents Manager at a Spanish patent attorney firm.
He was Director of the Technology Transfer Office of the Andalusian Public Healthcare System (practical experience in Spanish civil, administrative and commercial law, and in advanced therapies (stem cells and tissue engineering, nanotechnology and gene therapy)). He obtained the title of Spanish Industrial Property Attorney, the title of European Patent Attorney and the CEIPI Diploma inPatent Litigation in Europe.
He is currently studying a Master’s Degree in Bioinformatics and the Computer Engineering Degree (UOC – Universitat Oberta de Catalunya). He joined HOFFMANN EITLE in 2011.

# RICHARD SMITH BIO
Richard Smith is a British and European Patent Attorney with a background in Physics. He is fluent in both English and Spanish. He belongs to the Chartered Institute of Patent Attorneys, and the EPI. He specialises in patent drafting and prosecution before the European Patent Office and theUK Intellectual Property Office and opinion work concerning patentability and freedom-to-operate studies. Richard also manages a number of worldwide portfolios including in countries such as the US, China, Japan and Australia.
His fields of expertise are the electrical, mechanical and software fields, including medical devices and medical software. Regarding his career, he studied Physics at Oxford University (2009-2013), specialising in condensed matter physics and laser physics. He obtained the Certificate in Intellectual Property Law at Queen Mary University of London in 2015. He joined the London office of HOFFMANN EITLE in 2017. He is a European and British Patent Attorney since 2018.

🍻 XARTEC SALUT TALKS! After Office 🍻
2022-04-21 18:30 - 20:30
Acompanya’ns el dijous 21 d’abril a les “XARTEC SALUT TALKS”!

Tindrà lloc a La Vaca Coworking (Carrer de la Creu dels Molers, 19, 08004 Barcelona) a les 18h30 i té l’objectiu de crear entorns informals d’innovació oberta que facilitin el networking i la creació de sinergies. Tot això mentre ens prenem unes cerveses!

En aquesta ocasió, el tema principal serà sobre la Realitat Virtual/ Realitat Augmentada i comptarem amb el pitch de Xavier Palomer, CEO de la primera plataforma de realitat virtual, totalment immersiva, dissenyada per a la millora de la pràctica clínica dels professionals que treballen en salut mental, Amelia Virtual Care (anteriorment Psious).

També comptarem amb alguns grups de recerca de la Xartec Salut que ens explicaran què s’està “cuinant” en els laboratoris entorn d’aquesta tecnologia.

Adjuntem un flyer per a més informació i difusió!
Xartec Salut Talks – Flyer

Esperem veure’t allà! Recorda inscriure’t al link!

Incubation Training - Xartec Salut Programme: Presentation & Winning teams
2022-04-26 09:30 - 11:00
Register here
Formative programme of 12 sessions aimed to elevate the knowledge of spin-off founders in their process to scale up their technologies in the entrepreneurship atmosphere.

CALENDAR

26/4: By Francisco Badía on “Presentation & Winning teams”
3/5: By Gerard Compte on “Outbound Marketing”
10/5: By Ana Alonso and Marc Argemí on “Communication & PR”
17/5: By Roger Cuscó and JM Falguera on “OKRs”
24/5: By Susana Rubio on “Human Resources”
31/5: By Francisco Badía on “Financial Projections”
7/6: By Marisa Barros on “The failure”
14/6: By Josep Mª Roura and Pedro González-Anta on “Constitution & Start-Up”
21/6: By Elena Rico on “Investors & Partners Agreement”
28/6: By Mireia Mir on “Public Funding”
5/7: By Francisco Badía on “Business Valorization”
12/7: By Francisco Badía on “Negotiation”

From 9.30 a.m to 11.00 a.m every single tuesday (beginning the 26th April and finishing the 12th of July).
Join here: https://meet.google.com/zxs-ixwe-xem

Incubation Training Xartec Salut

Incubation Training - Xartec Salut Programme: Outbound Marketing
2022-05-03 09:30 - 11:00
Every tuesday from 26/04 until 12/07
Incubation Training
Register here
Formative programme of 12 sessions aimed to elevate the knowledge of spin-off founders in their process to scale up their technologies in the entrepreneurship atmosphere.

CALENDAR

26/4: By Francisco Badía on “Presentation & Winning teams”
3/5: By Gerard Compte on “Outbound Marketing”
10/5: By Ana Alonso and Marc Argemí on “Communication & PR”
17/5: By Roger Cuscó and JM Falguera on “OKRs”
24/5: By Susana Rubio on “Human Resources”
31/5: By Francisco Badía on “Financial Projections”
7/6: By Marisa Barros on “The failure”
14/6: By Josep Mª Roura and Pedro González-Anta on “Constitution & Start-Up”
21/6: By Elena Rico on “Investors & Partners Agreement”
28/6: By Mireia Mir on “Public Funding”
5/7: By Francisco Badía on “Business Valorization”
12/7: By Francisco Badía on “Negotiation”

From 9.30 a.m to 11.00 a.m every single tuesday (beginning the 26th April and finishing the 12th of July).
Join here: https://meet.google.com/zxs-ixwe-xem

Incubation Training Xartec Salut

Xartec Salut – TRAINING PILL – Venture Capital in Healthcare sector
2022-05-05 11:00 - 12:30
Venture Capital in Healthcare sector
– Mireia Angulo –
Brief description of the session /register
This is an introductory session to understand what a specialized Venture Capital (VC) is and how it works. We will cover basic concepts of:

Start-up financing options.
Fundraising materials to attract the investors.
The investment process followed by VCs to select the opportunities.
Negotiation with VCs.

Mireia Angulo is an Investment Analyst in Caixa Capital Risc, the Venture Capital arm of Criteria Caixa. She focuses on the Life sciences sector, investing in companies developing therapeutics, diagnostic products and medical devices and board member of several portfolio companies. Prior to Caixa Capital Risc, Mireia was an Investment Analyst at Healthequity, a venture capital fund focused on the healthcare sector. In addition, he held several positions in the public sector working for the technology transfer office of the University of Barcelona and the Clinical Hospital of Barcelona. Mireia holds a PhD in Genetics from University of Barcelona and earned her MBA from EADA business school.

Entrepreneurship Academy - Xartec Salut Programme: HOW TO CROSS TECH TRANSFER'S VALLEY OF DEATH
2022-05-10 04:00 - 18:00
May 10th – Marta Príncep, CEO & CoFounder BHV Partners – PhD
4 Sessions aimed to inspire doctoral students in entrepreneurship and TechTransfer in health sector.
Venue: Aula 13 Diagonal, 647, Planta 4 CREB UPC, 08028 Barcelona.
Session that addresses issues of good technology transfer practices, and exposes at a high level the path from the idea to the market in the health sector.

****SESSIONS WILL BE IN SPANISH*****

Incubation Training - Xartec Salut Programme: Communication & PR
2022-05-10 09:30 - 23:00

Incubation Training - Xartec Salut Programme: OKRs
2022-05-17 09:30 - 11:00

Entrepreneurship Academy - Xartec Salut Programme: SAVE LIVES WITH HEALTH TECHNOLOGY TRANSFER
2022-05-18 16:00 - 18:00
Register here
The Entrepreneurship Academy is a program of sessions designed to inspire doctoral students in promoting entrepreneurship and technology transfer in the health sector. This second session is of an Inspirational type and has the objective of making visible the usefulness of the transfer and the impact on the market of the research projects that have reached the market. This session will be taught by Pau Gimeno, Executive Vice President of the Richi Childhood Cancer Foundation and Head of the Richi Entrepreneurs Boston Immersion Program.
This event will take place in the Sala Trovatore of the Hotel Catalonia Rigoletto (Carrer de Sabino Arana, 22, 24, 08028) from 16h00 to 18h00.

****SESSIONS WILL BE IN SPANISH*****

Xartec Salut – TRAINING PILL – Keys and databases for the valorization of biomedical technologies
2022-05-19 11:00 - 12:30
Register here
Session description
This session covers different points for performing the valorization of biomedical technologies, focusing on different points such as market analysis, identification of competing technologies, relevant company’s search, etc. The objective of the lecture is to show different techniques for technology valorization, as well as relevant databases to be used by the researchers and innovation staff for free. This session packs a lot of resources and practical information in a format aimed to be directly used in most of technologies.
Short bio
Vicente’s background is in Human Biotechnology, holding an MBA and a Master in Business Creation and Intellectual Property by the University of Gothenburg. Vicente’s experience ranges from pharmaceutical sales, Intellectual property, business development, and tech-transfer. Currently, he is co-founder and co-director of Viromii, a consultancy firm focused on supporting valorization and tech-transfer operations of public and private R&D institutions.

Incubation Training - Xartec Salut Programme: Human Resources
2022-05-24 09:30 - 11:00
Every tuesday from 26/04 until 12/07
Incubation Training
Register here
Formative programme of 12 sessions aimed to elevate the knowledge of spin-off founders in their process to scale up their technologies in the entrepreneurship atmosphere.

CALENDAR

26/4: By Francisco Badía on “Presentation & Winning teams”
3/5: By Gerard Compte on “Outbound Marketing”
10/5: By Ana Alonso and Marc Argemí on “Communication & PR”
17/5: By Roger Cuscó and JM Falguera on “OKRs”
24/5: By Francisco Badía on “Human Resources”
31/5: By Francisco Badía on “Financial Projections”
7/6: By Marisa Barros on “The failure”
14/6: By Josep Mª Roura and Pedro González-Anta on “Constitution & Start-Up”
21/6: By Elena Rico on “Investors & Partners Agreement”
28/6: By Mireia Mir on “Public Funding”
5/7: By Francisco Badía on “Business Valorization”
12/7: By Francisco Badía on “Negotiation”

From 9.30 a.m to 11.00 a.m every single tuesday (beginning the 26th April and finishing the 12th of July).
Join here: https://meet.google.com/zxs-ixwe-xem

Incubation Training Xartec Salut

Entrepreneurship Academy - Xartec Salut Programme: SELF AWARENESS TO SUCEED
2022-05-25 16:00 - 18:00
Register here
The Entrepreneurship Academy is a program of sessions designed to inspire doctoral students in promoting entrepreneurship and technology transfer in the health sector. This third session will be a practical self-knowledge session. What is my type of leadership like? How is my way of interacting with the world? Who do I have the most affinity with and how does this affect teamwork? How can knowing me make me better in the professional environment? These are some of the questions that will be worked on in the practical workshop with the aim of knowing oneself better and improving teamwork. The mentor is Álvaro Ximénez de Olaso, founding partner of Mr Change Transformation Enabler & Executive Coaching.
This event will take place in the Sala Trovatore of the Hotel Catalonia Rigoletto (Carrer de Sabino Arana, 22, 24, 08028) from 16h00 to 18h00.

****SESSIONS WILL BE IN SPANISH*****

Incubation Training - Xartec Salut Programme: Financial Projections
2022-05-31 09:30 - 11:00

Entrepreneurship Academy - Xartec Salut Programme: STARTUP AS A TOOL TO BRING HEALTHTECH TO THE MARKET
2022-06-01 16:00 - 18:00
Register here
The Entrepreneurship Academy is a program of sessions designed to inspire doctoral students in promoting entrepreneurship and technology transfer in the health sector. This session is of an inspirational nature and will focus on health startups, their life cycle and operation as an agile tool to transfer technologies to the market and test business models. This session will be mentored by Joao Curado, CEO and founder of Flomix Biotech.
This event will take place in the Sala Trovatore of the Hotel Catalonia Rigoletto (Carrer de Sabino Arana, 22, 24, 08028) from 4:00 p.m. to 6:00 p.m.

****SESSIONS WILL BE IN SPANISH*****

Incubation Training - Xartec Salut Programme: The failure
2022-06-07 09:30 - 23:00
Register here
Formative programme of 12 sessions aimed to elevate the knowledge of spin-off founders in their process to scale up their technologies in the entrepreneurship atmosphere.

CALENDAR

26/4: By Francisco Badía on “Presentation & Winning teams”
3/5: By Gerard Compte on “Outbound Marketing”
10/5: By Ana Alonso and Marc Argemí on “Communication & PR”
17/5: By Roger Cuscó and JM Falguera on “OKRs”
24/5: By Susana Rubio on “Human Resources”
31/5: By Francisco Badía on “Financial Projections”
7/6: By Marisa Barros on “The failure”
14/6: By Josep Mª Roura and Pedro González-Anta on “Constitution & Start-Up”
21/6: By Elena Rico on “Investors & Partners Agreement”
28/6: By Mireia Mir on “Public Funding”
5/7: By Francisco Badía on “Business Valorization”
12/7: By Francisco Badía on “Negotiation”

From 9.30 a.m to 11.00 a.m every single tuesday (beginning the 26th April and finishing the 12th of July).
Join us at: Aula 13 Diagonal, 647, Planta 4 CREB UPC, 08028 Barcelona.

Incubation Training Xartec Salut

Incubation Training - Xartec Salut Programme: Constitution & Start-Up
2022-06-14 09:30 - 23:00

Incubation Training - Xartec Salut Programme: Investors & Partners Agreement
2022-06-21 09:30 - 23:00
Register here
Formative programme of 12 sessions aimed to elevate the knowledge of spin-off founders in their process to scale up their technologies in the entrepreneurship atmosphere.

CALENDAR

26/4: By Francisco Badía on “Presentation & Winning teams”
3/5: By Gerard Compte on “Outbound Marketing”
10/5: By Ana Alonso and Marc Argemí on “Communication & PR”
17/5: By Roger Cuscó and JM Falguera on “OKRs”
24/5: By Susana Rubio on “Human Resources”
31/5: By Francisco Badía on “Financial Projections”
7/6: By Marisa Barros on “The failure”
14/6: By Josep Mª Roura and Pedro González-Anta on “Constitution & Start-Up”
21/6: By Francisco Badía on “Investors & Partners Agreement”
28/6: By Carles Otero on “Public Funding”
5/7: By Xavier Vengohechea on “Business Valorization”
12/7: By Francisco Badía on “Negotiation”

From 9.30 a.m to 11.00 a.m every single tuesday (beginning the 26th April and finishing the 12th of July).
Join here: https://meet.google.com/zxs-ixwe-xem

Incubation Training Xartec Salut

Xartec Salut Roundtable "WORLDWIDE BEST PRACTICES FOR TECH TRANSFER IN HEALTHTECH"
2022-06-27 12:00 - 14:00
Register here
Xartec Salut invites you coming June 27 to the Round Table for successful technology transfer in the HealthTech sector, worldwide.
The objective that is intended with this act is to share best practices and collaborate internationally to promote that research results have a real social and economic impact.
To the meeting will attend four specialists from different countries

Elena Canetti, Co Managing Partner at Inveniam Group (Israel and Spain)
Antonio Gomez, Alliance Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson (Spain)
Bernard Munos, Senior Fellow at Faster Cures (United States)
Henric Rhedin, Director External Research & Exploration Coordination at Volvo Cars (Sweden).

This is an online event that will take place on the following link

Incubation Training - Xartec Salut Programme: Public Funding
2022-06-28 09:30 - 23:00

Incubation Training - Xartec Salut Programme: Business Valorization
2022-07-05 09:30 - 23:00

Incubation Training - Xartec Salut Programme: Negotiation
2022-07-12 09:30 - 23:00
Register here
Formative programme of 12 sessions aimed to elevate the knowledge of spin-off founders in their process to scale up their technologies in the entrepreneurship atmosphere.

CALENDAR

26/4: By Francisco Badía on “Presentation & Winning teams”
3/5: By Gerard Compte on “Outbound Marketing”
10/5: By Ana Alonso and Marc Argemí on “Communication & PR”
17/5: By Roger Cuscó and JM Falguera on “OKRs”
24/5: By Susana Rubio on “Human Resources”
31/5: By Francisco Badía on “Financial Projections”
7/6: By Marisa Barros on “The failure”
14/6: By Josep Mª Roura and Pedro González-Anta on “Constitution & Start-Up”
21/6: By Francisco Badía on “Investors & Partners Agreement”
28/6: By Carles Otero on “Public Funding”
5/7: By Xavier Vengohechea on “Business Valorization”
12/7: By Francisco Badía on “Negotiation”

Venue: Aula 13 Diagonal, 647, Planta 4 CREB UPC, 08028 Barcelona.

Incubation Training Xartec Salut

CREB Council Meeting
2022-09-07 10:00 - 12:00

“Key legal aspects of a technology-based start-up” - Xartec Salut Formation
2022-10-20 11:00 - 12:30
Xartec Salut Formation – “Key legal aspects of a technology-based start-up”

We will review the generally acceptable practice in the distribution of the share capital, as well as the governing bodies of the start-up. The main documents that must be in place in any start-up and the main clauses that need to be present in such documents.
We will also discuss the main terms and conditions that we will usually find in an investments agreement and the main aspects to manage and limit the responsibility of the founders. We will also visit the modalities of investments and the main instruments available for such investments. We will review a numeric example to calculate the percentage of the share capital that a pre-money valuation may represent.
We will also review the main types of investment plans for key employees, directors and collaborators as well as their main features.
We will analyze the main items involved in the transfer of technology from the institutions to the start-up and the international standards in such technology transfer. We will also review the structure of the license agreements, and the main terms and conditions of such agreements. We will discuss the main stages in the exploitation of the technology and the legal documents available in each of such stages.
In preparation for an eventual sale of an start-up, we will review a number of liquidation preference clauses that the investors usually require to be present in their investment and shareholders agreements.
We will also review the main aspects of the protection of personal data which is regulated by Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 Open in new window, on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulations) and the provisions of the Organic Law 3/2018, of 5 December, on Personal Data Protection and digital rights guarantee. We will analyze the main notions of data controller and registry of processing activities, the purpose and data categories, the legitimation or legal basis of the personal data processing, preservation of data, the transmission of data, international transfer of data, the legal rights of the interested parties, and the role of the data protection officer (DPO)​​.

Join here: https://meet.google.com/jir-wung-nur

"The adventure of creating a startup from the CSIC" – Xartec Salut Formation
2022-11-03 11:00 - 12:30
ABOUT THE SESSION
In January 2003 we got the approval of the Council of Ministers to create the first “sociedad limitada” in which the CSIC was a partner. The company was called Biopolis and focused on offering R&D services for the Spanish agri-food industry (technically a CRO).
After two years we were already generating profits and after four years we reinvested all the profits generated in founding Lifesequencing SL, the first Spanish massive genome company. In this adventure we were accompanied by Secugen SL, another CSIC spin-off. In the following years we expanded our capabilities in genomics, microbial physiology, animal models and scale-up and industrial production while increasing our customers in the European Union and LATAM until 2016, when we reached a staff of 45 professionals with a turnover of almost 4 million euros. It was then when we decided to offer a part of the shareholding for the entry of a new partner to help us grow in North America and APAC.
Then Archer Daniels Midland Co (ADM) arrived and acquired 90% of the shares. Since then we have been part of this large multinational agri-food company. They bought most of ADM’s shares because we were a company that developed ingredients using high-quality science as the driving force and that is what we continue to do.
Throughout this conference I will explain this journey and how my personal and professional life has changed over these twenty years.

ABOUT THE SPEAKER
He has a degree and a PhD in Biological Sciences from the University of Valencia. He did his PhD working at the Department of Molecular Genetics of the pharmaceutical company Antibioticos S.A. He carried out post-doctoral stays in the Wageningen University of Agriculture (The Netherlands).
He was Professor of Food Technology at the University of Valencia and Research Professor at the Institute of Agrochemistry and Food Technology (IATA) of the CSIC. He is currently on leave of absence from both academic responsibilities. In 2003 he founded the biotechnology company Biopolis S.L. specialized in microbial biotechnology and in 2008 the company Lifesequencing S.L. specialized in massive genome sequencing. Both companies were acquired in 2017 by the US multinational company Archer Daniels Midland Co (ADM).
He is currently Distinguished Research Fellow Microbiome at ADM and is the scientific director of the microbiome platform of this company. His technological results are protected by thirty patent families covering more than four hundred national and international patents, most of them transferred and in use. He has published more than 160 articles in prestigious international journals indexed in the Science Citation Index. He has been awarded the Prize of the Spanish Society of Microbiology, the Prize for Scientific Trajectory of the Danone Institute, the European Prize for Scientific Dissemination, the Juan de la Cierva National Research Prize, the International Hippocrates Prize, the Medal for Innovation of the García Cabrerizo Foundation and the International Nutrachampion Prize.
He is Full Member of the Royal Academy of Engineering of Spain.
He belongs to the Governing Council of the Spanish National Research Council.

Join here the formative session
